Breaking news: IRONMAN triathlon management givens 10 coachings two-year banned from ironman triathlon this morning due to rule violation after…..

Mexican triathlete Tomás Rodríguez Hernández has been handed a two-year ban for an anti-doping rule violation.

The Mexican star claimed victory at IRONMAN Texas back in April, completing his win with an astonishing 2:34:14 marathon.

 

But on August 6 the news came out of the International Testing Agency (ITA) that Rodríguez Hernández had returned an Adverse Analytical Finding for Clomifene (S4. Hormone and Metabolic Modulators). The sample was collected during an in-competition test at that IRONMAN Texas race on April 27.

 

Tomas Rodriguez Hernandez wins IRONMAN Texas in The Woodlands.

Tomás Rodríguez Hernández won IRONMAN Texas in April [Photo Credit: Kyle Rivas/Getty Images for IRONMAN].

 

The ITA statement confirmed that Rodríguez Hernández had been notified of the case, and has been provisionally suspended pursuant to Article 7.4.2 of the IRONMAN Anti-Doping Rules (IRONMAN ADR).

 

Rodríguez Hernández requested the opening and analysis of the B-sample, which confirmed the result of the A-sample. The athlete also challenged the imposition of the Provisional Suspension. He also released a statement protesting his innocence.

 

The Mexican star said: “The presence of Clomiphene in my system is due to the inadvertent consumption of contaminated food, specifically eggs and chicken, which are abundant in my diet.”

 

On Friday (September 13) we got a further update on the case, with the ITA confirming that Rodríguez Hernández has now been handed a two-year ban.

 

 

Ban confirmed by ITA

It said in a statement: “The International Testing Agency (ITA) on behalf of IRONMAN reports that Tomás Rodríguez Hernández, a triathlete from Mexico, has been sanctioned with a two-year period of ineligibility for an anti-doping rule violation (“ADRV”) under Article 2.1 of the IRONMAN Anti-Doping Rules (“IRONMAN ADR”) for the Presence of Clomifene.

 

 

Be the first to comment

Leave a Reply

Your email address will not be published.


*